Coronavirus, Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test

da Salute H24 — 21 marzo 2020 alle 12:05


Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert ®  Xpress SARS-CoV-2, a rapid molecular diagnostic test for qualitative detection of SARS-CoV-2,… Continua »

AntonioCaperna

Scrivi un commento